Market Tracker

10/31 7:05pm ET

Vical Inc (NASDAQ:VICL)

1.25
Data as of Oct 31
 +0.04 / +3.31%
Today’s Change
1.01
Today|||52-Week Range
1.79
+5.93%
Year-to-Date
Frontrunning: October 30
Oct 30 / Investing Channel
 

Today’s Trading

Previous close1.21
Today’s open1.20
Day’s range1.17 - 1.25
Volume1,032,494
Average volume (3 months)550,198
Market cap$107.2M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)+54.38%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.94%
P/E ratioNM
Price/Sales13.28
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc+0.15+10.79%
AFMDAffimed NV+0.28+6.31%
MRNSMarinus Pharmaceutic...-0.04-0.53%
SNSSSunesis Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 10/31/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$7.7M
Annual profit (last year)-$31.2M
Net profit margin-404.74%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts